Dennis M. Marcus, MD

Dr. Dennis Marcus discusses how the PDS with ranibizumab fits into the treatment landscape and explores other sustained delivery mechanisms currently in development for neovascular AMD.

Positioning PDS Within the Therapeutic Landscape

Video content above is prompted by the following:

How does the PDS with ranibizumab fit into the treatment landscape that also includes highly durable agents such as faricimab and high-dose aflibercept?

What other sustained delivery mechanisms are currently in development for neovascular AMD?

Videos

Refilling of PDS and Overall Safety Profile

What are the steps in the refill procedure for the port delivery system (PDS)? What are your thoughts on refilling the PDS every 6 months vs extending the interval?

What are the major adverse events associated with the PDS, and which patients are not suitable candidates for this delivery system?

Dr Marcus highlights procedure and safety overview for the port delivery system (PDS).

A retina surgeon reviews the key surgical steps for implanting the PDS, highlighting measures to prevent dislocation.

Key Surgical Steps for the Implantation of the PDS

Can you briefly walk us through the key surgical steps for the implantation of the PDS?

What steps can help prevent the dislocation of the PDS?

Efficacy and Patient Selection Criteria for PDS with Ranibizumab

What are the benefits of using the PDS with ranibizumab, and which patients are ideal candidates for this delivery method?

What do we know about the efficacy of the PDS with ranibizumab from the phase 3 ARCHWAY trial?

Dennis M. Marcus, MD

Articles